Trials / Completed
CompletedNCT00097513
National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients
National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Subjects
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- —
- Sponsor
- Genentech, Inc. · Industry
- Sex
- All
- Age
- 12 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
This study is a multicenter, open-label, observational, postmarketing surveillance study that will collect information on the use of Genentech GH preparations to treat GH-deficient subjects with optimal GH dosing during puberty.
Conditions
Timeline
- Start date
- 2003-02-01
- Completion
- 2006-06-01
- First posted
- 2004-11-25
- Last updated
- 2010-11-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00097513. Inclusion in this directory is not an endorsement.